- Home
- LCFY vs CELZ Comparison
LCFY vs CELZ Comparison
Compare LCFY & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LCFY | CELZ |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9M | 7.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LCFY | CELZ |
|---|---|---|
| Price | $3.99 | $1.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 82.6K | 43.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.50 | $1.50 |
| 52 Week High | $13.98 | $6.90 |
Technical Indicators
Market Signals| Indicator | LCFY | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 64.81 | 47.80 |
| Support Level | $2.98 | $1.83 |
| Resistance Level | $3.31 | $1.98 |
| Average True Range (ATR) | 0.34 | 0.13 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 79.68 | 52.78 |
Price Performance
Historical ComparisonAbout LCFY Locafy Limited
Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.